Literature DB >> 3530783

Interaction between cyclosporin and erythromycin in a kidney transplant patient.

M Kessler, J Louis, E Renoult, B Vigneron, P Netter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3530783     DOI： 10.1007/bf00542427

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  Cyclosporin.

Authors:  R Y Calne
Journal:  Nephron       Date:  1980       Impact factor: 2.847

2.  Antimicrobial susceptibility of intracellular Legionella pneumophila.

Authors:  M A Bacheson; H M Friedman; C E Benson
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

3.  Infections caused by Legionella micdadei and Legionella pneumophila among renal transplant recipients.

Authors:  J N Dowling; A W Pasculle; F N Frola; M K Zaphyr; R B Yee
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

4.  Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial.

Authors: 
Journal:  Lancet       Date:  1983-10-29       Impact factor: 79.321

Review 5.  Pharmacokinetic interactions of the macrolide antibiotics.

Authors:  T M Ludden
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447
  5 in total
  12 in total

Review 1.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

Review 3.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

4.  Spiramycin does not increase plasma cyclosporin concentrations in renal transplant patients.

Authors:  M Kessler; P Netter; M Zerrouki; E Renoult; P Trechot; B Dousset; B Jonon; J M Mur
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Lack of effect of spiramycin on cyclosporin pharmacokinetics.

Authors:  M Kessler; P Netter; H E Renoul; P Trechot; B Dousset; B Bannwarth
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

6.  Effect of josamycin on plasma cyclosporine levels.

Authors:  C Kreft-Jais; E M Billaud; C Gaudry; J Bedrossian
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Erythromycin enhances the absorption of cyclosporin.

Authors:  S K Gupta; A Bakran; R W Johnson; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

8.  Effect of ponsinomycin on cyclosporin pharmacokinetics.

Authors:  W Couet; B Istin; P Seniuta; D Morel; L Potaux; J B Fourtillan
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 9.  Macrolide antibacterials. Drug interactions of clinical significance.

Authors:  N A von Rosensteil; D Adam
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

Review 10.  Pharmacokinetic drug interactions of macrolides.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.